Honglin Tang
Sir Run Run Shaw Hospital
Hangzhou, 310020, China
Hangzhou, 310020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Prognostic Factors Analysis in Patients with Hepatocellular Carcinoma Receiving PD-1/PD-L1 Inhibitors.
Journal: Journal of hepatocellular carcinoma
Published: May 11, 2026
Targeting cellular source-specific CXCL9 signaling for immunotherapy in oral squamous cell carcinoma.
Journal: Frontiers in immunology
Published: December 16, 2025
Combination of anti-inflammatory therapy and RNA interference by light-inducible hybrid nanomedicine for osteoarthritis treatment.
Journal: Acta pharmaceutica Sinica. B
Published: April 03, 2024
A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy.
Journal: Acta biomaterialia
Published: January 22, 2024
Correction: Intracellular regulation of zinc by metal-organic framework-mediated genome editing for prostate cancer therapy.
Journal: Biomaterials science
Published: January 11, 2024
Erratum: Inflammation conditional genome editing mediated by the CRISPR-Cas9 system.
Journal: iScience
Published: July 17, 2023
Inflammation conditional genome editing mediated by the CRISPR-Cas9 system.
Journal: iScience
Published: October 16, 2022
A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
Journal: Acta biomaterialia
Published: September 20, 2022
A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 23, 2022
Exosomes and their roles in the chemoresistance of pancreatic cancer.
Journal: Cancer medicine
Published: March 07, 2022
A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders.
Journal: Signal transduction and targeted therapy
Published: January 04, 2022
Last Updated: 09/26/2026